亚太地区新发流感病毒威胁的临床应对策略
本文综述了亚太地区季节性流感、2009年A(H1N1)大流行及禽流感A(H5N1)、A(H7N9)等新发流感病毒的威胁,指出慢性病患者、高龄、孕妇、年轻成人和肥胖者为并发症高危人群。观察性研究显示神经氨酸酶抑制剂治疗成人重症流感可降低死亡率并改善临床结局,早期给药效果更佳,而大剂量全身性糖皮质激素与更差结局相关。
要点
- 慢性病、高龄、孕妇、年轻成人及肥胖者需警惕流感并发症风险
- 成人重症流感应尽早使用神经氨酸酶抑制剂以降低死亡率
- 大剂量全身性糖皮质激素与重症流感患者更差结局相关
核心结论
- 成人重症流感患者使用神经氨酸酶抑制剂与较低死亡率和更好临床结局相关,早期给药尤为重要。
- 大剂量全身性糖皮质激素与重症流感患者更差结局相关。
- 亟需开发更有效的抗流感病毒疗法。
研究设计与样本
- 本文为综述,汇总了季节性流感、2009年A(H1N1)大流行及禽流感A(H5N1)、A(H7N9)等新发流感病毒的临床应对证据。
主要发现
- 2009年A(H1N1)大流行期间年轻成人和肥胖个体风险增加。
- 自1997年和2013年起,禽流感A(H5N1)和A(H7N9)病毒在部分家禽种群中持续广泛传播并偶发感染人类。
- 中国内地近期人感染A(H7N9)病例数上升令人高度关注。
- 近年还出现了散发性人感染A(H5N6)、A(H10N8)和A(H6N1)病例,同时多国出现A(H5N8)禽类疫情。
- 观察性研究显示,成人重症流感住院患者使用神经氨酸酶抑制剂与较低死亡率和更好临床结局相关,早期给药效果更佳。
关键数值与推荐
- 成人重症流感住院患者使用神经氨酸酶抑制剂与较低死亡率和更好临床结局相关,尤其是病程早期给药。
- 大剂量全身性糖皮质激素与重症流感患者更差结局相关。
临床怎么用
- 对成人重症流感住院患者应尽早使用神经氨酸酶抑制剂治疗。
- 避免对重症流感患者使用大剂量全身性糖皮质激素。
局限性
- 关于高于标准剂量的神经氨酸酶抑制剂是否提供更大抗病毒效果,尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Seasonal influenza epidemics and periodic pandemics are important causes of morbidity and mortality. Patients with chronic co-morbid illness, those at the extremes of age and pregnant women are at higher risks of complications requiring hospitalization, whereas young adults and obese individuals were also at increased risk during the A(H1N1) pandemic in 2009. Avian influenza A(H5N1) and A(H7N9) viruses have continued to circulate widely in some poultry populations and infect humans sporadically since 1997 and 2013, respectively. The recent upsurge in human cases of A(H7N9) infections in Mainland China is of great concern. Sporadic human cases of avian A(H5N6), A(H10N8) and A(H6N1) have also emerged in recent years while there are also widespread poultry outbreaks due to A(H5N8) in many countries. Observational studies have shown that treatment with a neuraminidase inhibitor (NAI) for adults hospitalized with severe influenza is associated with lower mortality and better clinical outcomes, especially when administered early in the course of illness. Whether higher than standard doses of NAI would provide greater antiviral effects in such patients will require further investigation. High-dose systemic corticosteroids were associated with worse outcomes in patients with severe influenza. There is an urgent need for developing more effective antiviral therapies for treatment of influenza infections.
引用
- Hui DSC, Lee N, Chan PKS, et al. A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region. Respirology. 2017. PMID: 28677861. doi:10.1111/resp.13114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。